PBYI- Puma Biotechnology, Inc.

Across the last three months, Puma Biotechnology, Inc.'s insiders have reduced their positions by a net 44,058 shares worth roughly $364K.

PBYI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Auerbach Alan H	7.26M	$62.38M	-
CFO	Nougues Maximo F	240.0K	$2.06M	-
Other	Hunt Douglas M	205.3K	$1.76M	-
Dir	Miller Michael Patrick	54.0K	$463.9K	-

Buys and sells only

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 3, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	152	$9.91	$1,506.38	-0.2%	-24.4%	-76.4%
May 3, 2021	Hunt Douglas M62	See Remarks	Sell	417	$9.91	$4,132.64	-0.6%	-24.4%	-76.4%
May 3, 2021	Auerbach Alan H62	President And CEO	Sell	1,758	$9.01	$15,846.61	-	-24.4%	-76.4%
Apr 5, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	155	$9.80	$1,519.45	-0.2%	-12.7%	-66.9%
Apr 5, 2021	Hunt Douglas M62	See Remarks	Sell	426	$9.80	$4,176.04	-0.6%	-12.7%	-66.9%
Apr 5, 2021	Bryce Richard Paul	See Remarks	Sell	426	$9.80	$4,176.04	-0.3%	-12.7%	-66.9%
Apr 5, 2021	Auerbach Alan H62	President And CEO	Sell	1,584	$9.80	$15,527.79	-	-12.7%	-66.9%
Mar 2, 2021	Nougues Maximo F61	Chief Financial Officer	Sell	154	$10.14	$1,560.88	-0.2%	-	-
Mar 2, 2021	Hunt Douglas M62	See Remarks	Sell	422	$10.16	$4,288.28	-0.6%	-	-
Mar 2, 2021	Bryce Richard Paul	See Remarks	Sell	422	$10.15	$4,283.30	-0.3%	-	-